These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8657196)

  • 1. The antievolutionary component of antimutagenesis and anticarcinogenesis: where do mutation rates come from and where are they going?
    Drake JW
    Mutat Res; 1996 Feb; 350(1):5-8. PubMed ID: 8657196
    [No Abstract]   [Full Text] [Related]  

  • 2. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis: a summary.
    Liviero L; von Borstel RC
    Mutat Res; 1996 Feb; 350(1):287-93. PubMed ID: 8657193
    [No Abstract]   [Full Text] [Related]  

  • 3. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Banff, Canada, 4-9 September 1994.
    Mutat Res; 1996 Feb; 350(1):1-294. PubMed ID: 8657171
    [No Abstract]   [Full Text] [Related]  

  • 4. Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    De Flora S; Bronzetti G; Weisburger JH
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):95-9. PubMed ID: 1688263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention.
    De Flora S; Izzotti A; Bennicelli C
    Basic Life Sci; 1993; 61():1-16. PubMed ID: 8304921
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent developments in antimutagenesis and anticarcinogenesis.
    Levin M
    Drugs Today (Barc); 2002 Jul; 38(7):495-9. PubMed ID: 12582466
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimutagenesis/anticarcinogenesis 2001: mechanistic studies.
    Gentile JM; Gentile G; Lohman PH; Ferguson LR
    Mutat Res; 2001 Sep; 480-481():1-7. PubMed ID: 11506794
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches to antimutagenesis.
    Heddle JA; Moody J; Thompson LU; Torous DK; Trentin G
    J Environ Pathol Toxicol Oncol; 1999; 18(2):95-101. PubMed ID: 15281220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimutagenesis and anticarcinogenesis mechanisms. Proceedings of the International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. October 6-10, 1985, Lawrence, Kansas. Dedicated to Dr. Charlotte Auerbach and Dr. Takashi Sugimura.
    Basic Life Sci; 1986; 39():1-605. PubMed ID: 3533038
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanistic approaches to chemoprevention of mutation and cancer.
    Ferguson LR; Bronzetti G; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):3-7. PubMed ID: 16095634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimutagenesis and anticancer effects.
    Bronzetti G; Della Croce C; Aretini P; Fiorio R
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):59-64. PubMed ID: 9216786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The modifications of mutagenesis and anticarcinogenesis].
    Khudoleĭ VV
    Vestn Ross Akad Med Nauk; 1993; (1):34-41. PubMed ID: 7682121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the International Symposium on Antimutagenesis and Anticarcinogenesis. April 25-26, 2002, Valhalla, New York, USA.
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S1-108. PubMed ID: 12725235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carcinogenic mechanisms and anticarcinogenesis].
    Kavetskiĭ RE
    Vopr Onkol; 2005; 51(6):632-5. PubMed ID: 17037026
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimutagenesis/anticarcinogenesis 2001: screening, methods and biomarkers.
    Lohman PH; Gentile JM; Gentile G; Ferguson LR
    Mutat Res; 2001 Sep; 496(1-2):1-4. PubMed ID: 11551474
    [No Abstract]   [Full Text] [Related]  

  • 16. RBE-LET relationships in mutagenesis by ionizing radiation.
    Nikjoo H; Munson RJ; Bridges BA
    J Radiat Res; 1999 Dec; 40 Suppl():85-105. PubMed ID: 10804998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amber mutants of phage T4.
    Stahl FW
    Genetics; 1995 Oct; 141(2):439-42. PubMed ID: 8647382
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems and prospects in antimutagenesis and anticarcinogenesis.
    De Flora S
    Mutat Res; 1988 Dec; 202(2):279-83. PubMed ID: 3057361
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antimutagenesis as a genetic process].
    Goncharova RI
    Vestn Ross Akad Med Nauk; 1993; (1):26-33. PubMed ID: 7682119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-dependent antimutagenic activity of acrolein in Escherichia coli.
    Aikawa K; Miwa M
    Mutat Res; 1993 Feb; 301(2):93-7. PubMed ID: 7678176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.